Shift worker more likely to be overweight, experience sleep problems
the ONA take:
According to a new study published in the journal Sleep Health, researchers from the University of Wisconsin School of Medicine and Public Health in Madison have found that employees who work shifts outside of a 9-to-5 schedule are at an increased risk for being overweight, experiencing sleep problems, and possibly developing metabolic disorders, compared with people who work conventional schedules.
Specifically, results showed that shiftworkers were about 13% more likely to be overweight, approximately 7% more likely to experience insomnia, about 10% more likely to get insufficient sleep, and over 7% more likely to experience excessive wake-time sleepiness than traditional schedule workers.
Researchers also found that experiencing sleep problems was associated with metabolic disorders, such as being overweight/obese or diabetic.
"Shiftwork employees are particularly vulnerable to experiencing sleep problems as their jobs require them to work night, flex, extended, or rotating shifts," said Marjory Givens, PhD, Associate Scientist at the University of Wisconsin School of Medicine and Public Health.
"This study adds to a growing body of literature calling attention to the metabolic health burden commonly experienced by shiftworkers and suggests that obtaining sufficient sleep could lessen this burden.
Employees who work shifts outside of a 9-to-5 schedule are at an increased risk for being overweight.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Pediatric Hepatocellular Carcinoma: Challenges and Solutions
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|